Oncotarget
Crystal structure of the nSH2 and iSH2 of p85 with the p110α catalytic subunit. See Burke, Perisic, Williams.
Deregulation of the CDX2-KLF4 axis in acute myeloid leukemia and colon cancer |
https://doi.org/10.18632/oncotarget.896 Arefeh Rouhi, and Stefan Fröhling |
174-175 |
PDF | HTML | How to cite | Order a Reprint |
Unexpected Outcomes of CDK4/6 Inhibition |
https://doi.org/10.18632/oncotarget.912 Yoon Jong Choi, and Piotr Sicinski |
176-177 |
PDF | HTML | How to cite | Order a Reprint |
Signaling networks, network pathology and computational chemotherapy |
https://doi.org/10.18632/oncotarget.911 Kwang-Hyun Cho |
178-179 |
PDF | HTML | How to cite | Order a Reprint |
Allosteric activation of PI3Kα by oncogenic mutations |
https://doi.org/10.18632/oncotarget.913 John E Burke, Olga Perisic, and Roger L Williams |
180-181 |
PDF | HTML | How to cite | Order a Reprint |
Microbial Oncotarget: Bacterial-Produced Butyrate, Chemoprevention and Warburg Effect |
https://doi.org/10.18632/oncotarget.915 Dallas R. Donohoe, Kaitlin P. Curry, and Scott J. Bultman |
182-183 |
PDF | HTML | How to cite | Order a Reprint |
Calcein-effluxing human colon cancer cells are enriched for self-renewal capacity and depend on β-catenin |
https://doi.org/10.18632/oncotarget.883 Joshua E. Allen, and Wafik S. El-Deiry |
184-191 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
HPV16 E5 and KGFR/FGFR2b interplay in differentiating epithelial cells |
https://doi.org/10.18632/oncotarget.803 Valeria Purpura, Francesca Belleudi, Silvia Caputo, and Maria Rosaria Torrisi |
192-205 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
TRAIL induces apoptosis in oral squamous carcinoma cells: a crosstalk with oncogenic Ras regulated cell surface expression of death receptor 5 |
https://doi.org/10.18632/oncotarget.813 Jun-jie Chen, Constantinos M. Mikelis, Yaqin Zhang, J. Silvio Gutkind, and Baolin Zhang |
206-217 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Targeted alpha-therapy using [Bi-213]anti-CD20 as novel treatment option for radio- and chemoresistant non-Hodgkin lymphoma cells |
https://doi.org/10.18632/oncotarget.817 Mareike Roscher, Inis Hormann, Oliver Leib, Sebastian Marx, Josue Moreno, Erich Miltner, and Claudia Friesen |
218-230 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Comedo-DCIS is a precursor lesion for basal-like breast carcinoma: identification of a novel p63/Her2/neu expressing subgroup |
https://doi.org/10.18632/oncotarget.818 Malathy PV Shekhar, Ikuko Kato, Pratima Nangia-Makker, and Larry Tait |
231-241 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
In Vitro and in Vivo Anti-tumor Activity of miR-221/222 Inhibitors in Multiple Myeloma |
https://doi.org/10.18632/oncotarget.820 Maria Teresa Di Martino, Annamaria Gullà, Maria Eugenia Gallo Cantafio, Marta Lionetti, Emanuela Leone, Nicola Amodio, Pietro Hiram Guzzi, Umberto Foresta, Francesco Conforti, Mario Cannataro, Antonino Neri, Antonio Giordano, Pierosandro Tagliaferri, and Pierfrancesco Tassone |
242-255 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Ras inhibition boosts galectin-7 at the expense of galectin-1 to sensitize cells to apoptosis |
https://doi.org/10.18632/oncotarget.844 Batya Barkan, Adrienne D. Cox, and Yoel Kloog |
256-268 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Preclinical analyses of intravesical chemotherapy for prevention of bladder cancer progression |
https://doi.org/10.18632/oncotarget.852 Joan C Delto, Takashi Kobayashi, Mitchell C Benson, James McKiernan, and Cory Abate-Shen |
269-276 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Efemp1 and p27Kip1 modulate responsiveness of pancreatic cancer cells towards a dual PI3K/mTOR inhibitor in preclinical models |
https://doi.org/10.18632/oncotarget.859 Diersch Sandra, Patrick Wenzel, Melanie Szameitat, Philipp Eser, Mariel C Paul, Barbara Seidler, Stefan Eser, Marlena Messer, Maximilian Reichert, Philipp Pagel, Irene Esposito, Roland M Schmid, Dieter Saur, and Günter Schneider |
277-288 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
TAp73β-mediated suppression of cell migration requires p57Kip2 control of actin cytoskeleton dynamics |
https://doi.org/10.18632/oncotarget.833 Johanna Rodhe, Edel Kavanagh, and Bertrand Joseph |
289-297 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
DNA-intercalators Causing Rapid Re-expression of Methylated and Silenced Genes in Cancer Cells |
https://doi.org/10.18632/oncotarget.863 M. Zulfiquer Hossain, Megan A. Healey, Calvin Lee, Weijie Poh, Sashidhar R. Yerram, Kalpesh Patel, Nilofer S. Azad, James G. Herman, and Scott E. Kern |
298-309 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
BRAF Mutant Gastrointestinal Stromal Tumor: First report of regression with BRAF inhibitor dabrafenib (GSK2118436) and whole exomic sequencing for analysis of acquired resistance |
https://doi.org/10.18632/oncotarget.864 Gerald S. Falchook, Jonathan C. Trent, Michael C. Heinrich, Carol Beadling, Janice Patterson, Christel C. Bastida, Samuel C. Blackman, and Razelle Kurzrock |
310-315 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Growth of poorly differentiated endometrial carcinoma is inhibited by combined action of medroxyprogesterone acetate and the Ras inhibitor Salirasib |
https://doi.org/10.18632/oncotarget.867 Raya Faigenbaum, Roni Haklai, Gilad Ben-Baruch, and Yoel Kloog |
316-328 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Luteolin is a novel p90 ribosomal S6 kinase (RSK) inhibitor that suppresses Notch4 signaling by blocking the activation of Y-box binding protein-1 (YB-1) |
https://doi.org/10.18632/oncotarget.834 Kristen M. Reipas, Jennifer H. Law, Nicole Couto, Sumaiya Islam, Yvonne Li, Huifang Li, Artem Cherkasov, Karen Jung, Amarpal S. Cheema, Steven J.M. Jones, John A. Hassell, and Sandra E. Dunn |
329-345 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal |
https://doi.org/10.18632/oncotarget.868 Hae-Kyung Lee, Susan Finniss, Simona Cazacu, Efrat Bucris, Amotz Ziv-Av, Cunli Xiang, Kevin Bobbitt, Sandra Rempel, Laura Hasselbach, Tom Mikkelsen, Shimon Slavin, and Chaya Brodie |
346-361 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Actin-binding protein alpha-actinin 4 (ACTN4) is a transcriptional co-activator of RelA/p65 sub-unit of NF-kB. |
https://doi.org/10.18632/oncotarget.901 Vasilisa Aksenova, Lidia Turoverova, Mikhail Khotin, Karl-Eric Magnusson, Eugene Tulchinsky, Gerry Melino, George P Pinaev, Nikolai Barlev, and Dmitri Tentler |
362-373 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC